Crossmark

Janus kinase inhibitors as a therapeutic option in rheumatoid arthritis and associated interstitial lung disease. Report of four cases

Crossref DOI link: https://doi.org/10.1016/j.rcreue.2018.02.003

Published Print: 2019-04

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Saldarriaga-Rivera, Lina María

López-Villegas, Víctor Jaime
License Information

Text and Data Mining valid from 2019-04-01
More Information

This article is maintained by: Elsevier

Article Title: Janus kinase inhibitors as a therapeutic option in rheumatoid arthritis and associated interstitial lung disease. Report of four cases

Journal Title: Revista Colombiana de Reumatología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.rcreue.2018.02.003

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.rcreu.2018.02.002

Content Type: simple-article

Copyright: © 2018 Asociación Colombiana de Reumatología. Published by Elsevier España, S.L.U. All rights reserved.